SYK · NYSE
Stryker Corporation
$307.19 +0.04 (+0.01%)
Company overview
Stryker Corporation operates as a medical technology company. The company operates through two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products used in various medical specialties.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE
- Market cap
- $118B
- Employees
- 53,000
- Headquarters
- Portage, MI
- Website
- stryker.com
- CEO
- Kevin A. Lobo
- Listed
- March 17, 1980
- P/E
- 35.19
- Dividend yield
- 1.28%
Company financials
- Revenue
- $25.3B
- Gross profit
- $16.1B
- Operating income
- $5.4B
- EBITDA
- $5.8B
- Net income
- $3.3B
- EPS
- $8.73
- Total assets
- $46.3B
- Total debt
- $14.2B
- Gross margin
- 63.67%
- Net margin
- 13.21%
- Earnings yield
- 2.84%
Showing FY 2025
SYK
1D
NYSE
O299.80H309.68L299.36C307.08+9.48 (+3.19%)Vol2.80M